MCM
GILD icon

McRae Capital Management’s Gilead Sciences GILD Stock Holding History

McRae Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,922
Closed -$209K – 109
2016
Q4 		$209K Sell
2,922
-1,000
-25% -$74.3K 0.09% 94
2016
Q3 		$310K Sell
3,922
-100
-2% -$8.12K 0.14% 78
2016
Q2 		$336K Buy
4,022
+600
+18% +$53.2K 0.16% 71
2016
Q1 		$314K Buy
3,422
+952
+39% +$85.9K 0.14% 70
2015
Q4 		$250K Buy
2,470
+100
+4% +$10.4K 0.12% 67
2015
Q3 		$233K Hold
2,370
– – 0.12% 67
2015
Q2 		$277K Hold
2,370
– – 0.13% 62
2015
Q1 		$233K Sell
2,370
-484
-17% -$49.1K 0.11% 66
2014
Q4 		$269K Buy
2,854
+84
+3% +$8.69K 0.12% 66
2014
Q3 		$295K Buy
2,770
+100
+4% +$9.79K 0.14% 61
2014
Q2 		$221K Buy
+2,670
New +$208K 0.11% 70
2014
Q1 		– Sell
-2,710
Closed -$204K – 79
2013
Q4 		$204K Buy
+2,710
New +$189K 0.1% 76

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

McRae Capital Management's GILD Position: Q1 2017 in Review

McRae Capital Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 2,922 shares — an estimated $209K sold.

McRae Capital Management first reported a position in GILD in Q4 2013 and held it in 12 quarters. The position peaked at $336K in Q2 2016. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • McRae Capital Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • McRae Capital Management sold 2,922 Gilead Sciences shares in Q1 2017, an estimated $209K.
  • McRae Capital Management first reported a position in Gilead Sciences in Q4 2013 and held it in 12 quarters.
  • McRae Capital Management's Gilead Sciences position peaked at $336K in Q2 2016.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on McRae Capital Management's 13F filing for Q1 2017, filed 10 May 2017.